Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1631
This examiner grants 27% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17764892 | METHOD OF TREATING ARTERIOVENOUS MALFORMATIONS BY TARGETING THE EPHRIN PATHWAY | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18037740 | SKIN SPHEROIDS AND PROCESS OF PREPARATION AND USE THEREOF | Non-Final OA | BASF SE |
| 17613004 | ENDOCRINE DIFFERENTIATION-INDUCING MOLECULE | Non-Final OA | President and Fellows of Harvard College |
| 17996541 | GENETICALLY-MODIFIED CELL LINE FOR NK CELL ACTIVATION AND AMPLIFICATION, AND USE THEREOF | Non-Final OA | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION |
| 17180696 | NAÏVE HUMAN EMBRYONIC VASCULAR PROGENITOR CELLS AND METHODS OF TREATMENT | Non-Final OA | The Johns Hopkins University |
| 16981800 | Detection of Interaction Between an Assay Substance and Blood or Blood Components for Immune Status Evaluation and Immune-Related Disease Detection and Diagnosis | Non-Final OA | UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy